Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Celprogen reveals pancreatic stem cell stimulator STEMC-7007

May 13, 2015

Takeda discloses SSTR5 antagonists

May 12, 2015

ProMetic selects C1-INH for development

May 11, 2015

Clcn7G213R-siRNA rescues osteoclast function in ADO2 model

May 11, 2015

Zealand Pharma and Boehringer Ingelheim disclose glucagon analogues

May 8, 2015

EMA committee recommends approval of new Orfadin formulations

May 8, 2015

Transition Therapeutics licenses SARM TT-701 from Lilly

May 8, 2015

E.U. marketing submission for GSK-2696273 gene therapy to treat ADA-SCID

May 7, 2015

Global Enterprises Group launches personalized medicine developer Predictive Therapeutics

May 7, 2015

Merck & Co. patents cathepsin K inhibitors

May 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...